Association of Soluble Tumor Necrosis Factor Receptors 1 and 2 With Nephropathy, Cardiovascular Events, and Total Mortality in Type 2 Diabetes

Cardiovascular Diabetology - United Kingdom
doi 10.1186/s12933-016-0359-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Total Plasma Homocysteine and Arteriosclerotic Outcomes in Type 2 Diabetes With Nephropathy

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2005English

Tumor Necrosis Factor Alpha in Peripheral Neuropathy in Type 2 Diabetes Mellitus

Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Mental HealthPsychiatric Mental HealthNeurologyPsychiatryNeuroscienceSurgery
2019English

Glucose-Lowering With Exogenous Insulin Monotherapy in Type 2 Diabetes: Dose-Response Association With All-Cause Mortality, Cardiovascular Events, and Incident Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Early Prediction of Nephropathy and Cardiovascular Diseases in Indian Patients With Type 2 Diabetes Mellitus

International Journal of Medical Science and Public Health
2014English

Association of Diabetic Nephropathy With Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients

International Journal of Advances in Medicine
2019English

Soluble Interleukin-2 Receptor and Tumor Necrosis Factor Levels in Depressed Patients in Estonia

Medicina
Medicine
2009English

Clinical Study of Association of Bmi With Nephropathy in Patients With Type 2 Diabetes Mellitus

Journal of Evidence Based Medicine and Healthcare
2019English

Soluble Tumor Necrosis Factor- Receptors in Young Obese Subjects With Normal and Impaired Glucose Tolerance

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2003English

Association of TGF-β1 Polymorphism With Type 2 Diabetes Mellitus and Diabetic Nephropathy in Saudi Patients

International Journal of Advanced Research
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy